期刊文献+

尿酸与心血管疾病关系的研究进展 被引量:6

Advances in Research on Relationship between Uric Acid and Cardiovascular Diseases
原文传递
导出
摘要 尿酸是人体嘌呤代谢的终末产物,主要通过肾脏排出体外。随着人们生活方式的改变,高尿酸血症的发病率呈逐年上升趋势。大量研究表明尿酸与心血管疾病关系密切。综述尿酸的代谢、尿酸与常见心血管疾病的关系、尿酸参与心血管疾病的可能作用机制以及降尿酸药物对心血管的保护作用,以期为相关研究提供参考。 Uric acid(UA),the end-product of purine metabolism in human,is mainly excreted through the kidneys.With the change of our lifestyles,the incidence of hyperuricemia is getting higher every year.The close relationship between uric acid and cardiovascular disease(CVD)has been recognized from a number of studies.This review summarizes the metabolism of uric acid,the correlation between uric acid and CVD,the potential mechanism of uric acid involvement in CVD,as well as the protective effect of uric acidlowering drugs on CVD,aiming to provide evidence for related research.
作者 杨柳 孔炜 YANG Liu;KONG Wei(Department of Physiology and Pathophysiology,Peking University Health Science Center,Beijing 100191,China)
出处 《药学进展》 CAS 2020年第12期883-893,共11页 Progress in Pharmaceutical Sciences
基金 国家自然科学基金重点项目(No.81730010,No.31930056) 国家自然科学基金创新研究群体项目(No.81921001)。
关键词 尿酸 心血管疾病 降尿酸药物 uric acid cardiovascular disease uric acid-lowering drug
  • 相关文献

参考文献2

二级参考文献30

  • 1Feig DI, Kang DH, Nakagawa T, Mazzali M, Johnson RJ. Uric acid and hypertension. Curr Hypertens Rep 2006; 8: 111-5.
  • 2Gertzberg N, Neumann P, Rizzo V, Johnson A. NAD(P)H oxidase mediates the endothelial barrier dysfunction induced by TNF-alpha. Am J Physiol Lung Cell Mol Physiol 2004; 286: L37-48.
  • 3Cave AC, Brewer AC, Narayanapanicker A, Ray R, Grieve DJ, Walker S, et al. NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal 2006; 8: 691-728.
  • 4Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001; 38: 1101-6.
  • 5Watanabe S, Kang DH, Feng L, Nakagawa T, Kanellis J, Lan H, et al. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension 2002; 40: 355-60.
  • 6Itoh H, Higuchi H, Hiraoka N, Ito M, Konishi T, Nakano T, et al. Contraction of rat thoracic aorta strips by endothelin-1 in the absence of extracellular Ca2+. Br J Pharmacol 1991; 104: 847-52.
  • 7Cai L, Kang YJ. Oxidative stress and diabetic cardiomyopathy: a brief review. Cardiovasc Toxicol 2001; 1: 181-93.
  • 8Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 2007; 293: C584-96.
  • 9Iglarz M, Schiffrin EL. Role of endothelin-1 in hypertension. Curr Hypertens Rep 2003; 5: 144-8.
  • 10Ergul A. Endothelin-1 and endothelin receptor antagonists as potential cardiovascular therapeutic agents. Pharmacotherapy 2002; 22: 54-65.

共引文献57

同被引文献42

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部